News und Analysen
Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 46th Annual Raymond James Institutional Investors Conference on Tuesday, March 4th.
The
EQS-News: Eckert & Ziegler Enters Strategic Partnership with Bicycle Therapeutics for Radioisotope Supply and Contract Development and Manufacturing of Bicycle Radio Conjugates
EQS-News: MEDICLIN presents preliminary figures for the 2024 financial year
Sonova raises awareness for hearing health globally
Agilent Reports First-Quarter Fiscal Year 2025 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up 1.2% core(1) compared to the first
Chemed Reports Fourth-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
STAAR Surgical Announces Leadership Transition
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership
Humana Expands Value-Based Oncology Care Through New Agreement with Thyme Care
Humana Inc. (NYSE: HUM), a leading health and well-being company, today introduced a new value-based care agreement with Thyme Care to provide comprehensive cancer care support for eligible Humana
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45th Annual Health Care Conference on Tuesday, Mar. 4, 2025.
Scott Ullem, chief financial officer
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported fourth-quarter and full-year 2024 results and issued full-year 2025 guidance.
Financial Summary and
EQS-News: Eckert & Ziegler Ensures Business Continuity After Cyber-Attack
Humana Foundation Donates $250,000 to Support Disaster Recovery in the Wake of Catastrophic Flooding in Kentucky
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), is donating $250,000 in support of relief and recovery efforts for Kentuckians impacted by destructive flooding in Eastern
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine
Acadia Healthcare to Participate in March Investor Conferences
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March.
On Tuesday, March 4, 2025, the Company will participate in
LivaNova to Present at the Barclays Global Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global
Agilent Announces Cash Dividend of 24.8 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on April 23, 2025, to all shareholders of
Premier, Inc. Enters Into $200 Million Accelerated Share Repurchase Program
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that it has entered into accelerated share repurchase agreements with JPMorgan Chase Bank
Siegfried reports continued profitable growth fueled by strong underlying business
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech releases Universal Registration Document 2024
Chemed Corporation Declares Quarterly Dividend of 50 Cents
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2024.
Fourth Quarter 2024 Financial Highlights:
-
Revenue grew 8%
Humana and Monogram Health Announce Expansion of Comprehensive Kidney Care Program
Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and its underlying causes. Eligible Humana Medicare



